PlusCBD™ Oil Roll-On establish at 945 Kroger shops in 17 U.S. States
VEGAS, June 12, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a supplier that is preeminent maker of hemp CBD items, is very happy to announce further expansion of its industry-dominating PlusCBD™ Oil brand name with all the Kroger Co. (NYSE:KR).
The Company’s expanded distribution that is retail the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger shops across a lot of its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths places in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and further Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant components, warming camphor and menthol that is cooling. Created using its Gold Formula focused complete spectrum hemp extract, the Roll-Ons offer high strength support in an application that is easy-to-use. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms may also be available at the participating Kroger areas. All PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and are made without artificial dyes or scents to meet consumer expectations of clean ingredients.
As discussed regarding the Company’s very first quarter 2019 profits call on May 8, 2019, CV Sciences’ recent distribution gains include option of PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy shops. By adding 945 Kroger places and brand new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded products are obtainable in 4,591 stores, up from 3,308 retail stores at the time of March 31, 2019, a rise of 38.7% within the previous 8 weeks.
“We are happy to partner with Kroger and introduce our Roll-On that is new topical we carry on our fast expansion in to the FDM channel,” said Joseph Dowling, ceo. “Kroger, CVS Pharmacy, and other leading nationwide retailers are keenly alert to the increased consumer need for hemp-based CBD items and are partnering with CV Sciences as a result of our unwavering dedication to security and quality. We have been at the start of what we think will likely to be acceptance that is broad of products across national FDM reports so we look ahead to our continued growth even as we increase store count and SKUs with this retail lovers.”
PlusCBD™ Oil Extra Strength Balm ranks no. 1 in product sales both in the Total U.S. Natural Channel and complete U.S. MULO (Multi Outlet) over the past 52 months* among CBD services and services and products within Topical Analgesics, based on SPINS and IRI information, correspondingly. Brightfield Group, a prominent predictive analytics and marketing research company when it comes to CBD market, expects $1.3 billion in product product sales of CBD topicals in 2019, having an ingredient yearly development rate of 169% from 2018 – cbd oil what is 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct company sections: a customer product unit centered on production, advertising and attempting to sell plant-based CBD items to a selection of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company’s PlusCBD™ Oil could be the top-selling model of hemp-derived CBD available on the market, according to SPINS, the best provider of syndicated information and insights for the normal, natural and specialty items industry. CV Sciences, Inc. has primary workplaces and facilities in north park, Ca and Las vegas, nevada, Nevada. Extra information can be obtained from OTCMarkets.com or by visiting www.cvsciences.com.
This news release may contain specific forward-looking statements and information, as defined inside the concept of Section 27A of this Securities Act of 1933 and Section 21E associated with the Securities Exchange Act of 1934, and it is at the mercy of the secure Harbor produced by those parts. This material contains statements about anticipated future occasions and/or monetary outcomes which can be forward-looking in general and at the mercy of dangers and uncertainties. Such forward-looking statements by meaning incorporate dangers, uncertainties.